Sentences with phrase «synovial cell sarcoma»

Synovial cell sarcoma and chrondosarcoma originate in the connective tissues around the joints and invade the bone.

Other types of bone cancers include synovial cell sarcoma, hemangiosarcoma, chondrosarcoma and fibrosarcoma.

The most common tumors of the joint include synovial cell sarcoma, histiocytic sarcoma, myxomas and other sarcomas.

Not exact matches

Adenocarcinoma of the Appendix, Anal cancer, Breast Cancer, Cancer, Squamous cell carcinoma, Colorectal Cancer, Esophageal Cancer, Esthesioneuroblastoma, Hodgkin lymphoma, Intrahepatic cholangiocarcinoma, Laryngeal cancer, Lip and oral cavity cancer, Liposarcoma, Liver cancer, Multiple myeloma, Nasopharyngeal carcinoma, Non-small cell lung cancer, Oral cancer, Osteosarcoma, Pancreatic cancer, Rectal Cancer, Salivary Gland Cancer, Stomach cancer, Synovial sarcoma, Testicular cancer, Tongue cancer, Vaginal cancer, Bladder cancer, Cervical cancer, Prostate cancer, Non-Hodgkin lymphoma, Brain Cancer, Thyroid Cancer, Ewing Sarcoma, Extrahepatic bile duct cancer, Msarcoma, Testicular cancer, Tongue cancer, Vaginal cancer, Bladder cancer, Cervical cancer, Prostate cancer, Non-Hodgkin lymphoma, Brain Cancer, Thyroid Cancer, Ewing Sarcoma, Extrahepatic bile duct cancer, MSarcoma, Extrahepatic bile duct cancer, Melanoma

Steven A. Rosenberg and colleagues at the Surgery Branch of the National Cancer Institute demonstrate that adoptive immunotherapy with CD8 + T cells genetically engineering to recognize the NY - ESO - 1 antigen could induce significant tumor regressions in patients with metastatic synovial sarcoma and melanoma.

Synovial sarcoma is a cancer in the joints with a five - year and ten - year survival for people with Grade 3 tumors or metastatic disease of less than 25 % and 15 %, respectively, and Myxoid round cell liposarcoma is a malignant tumor that most often occurs in the deep - seated soft tissues of the extremities.

Soft Tissue Sarcoma Opportunity: in both our monotherapy single arm Phase 1 and combination randomized Phase 2 studies, we are focusing on two types of sarcoma where we believe there is significant unmet need: synovial sarcoma and Myxoid round cell liposSarcoma Opportunity: in both our monotherapy single arm Phase 1 and combination randomized Phase 2 studies, we are focusing on two types of sarcoma where we believe there is significant unmet need: synovial sarcoma and Myxoid round cell lipossarcoma where we believe there is significant unmet need: synovial sarcoma and Myxoid round cell lipossarcoma and Myxoid round cell liposarcoma.

The randomized, open label Phase 2 trial is ongoing and evaluating CMB305 and atezolizumab in patients with locally advanced, relapsed, or metastatic synovial sarcoma or myxoid / round - cell liposarcoma, two types of sarcoma that tend to express NY - ESO - 1 broadly.